3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Cardiotoxicity
14
Breast Neoplasms
10
Neoplasms
4
Heart Failure
4
Heart Diseases
2
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Metabolic Syndrome
1
Memory Disorders
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Dyspnea
1
Dyslipidemias
1
Cognitive Dysfunction
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Bone Neoplasms
1
Atherosclerosis
1
Interventions
Standard of Care
2
Blood Specimen Collection
2
epicatechin gallate
1
Vascular Stiffness
1
Valsartan
1
Therapeutics
1
Specimen Handling
1
Restraint, Physical
1
Pulse Wave Analysis
1
Practice Guidelines as Topic
1
Mesenchymal Stem Cell Transplantation
1
Exercise
1
Electronic Health Records
1
Electrocardiography
1
Echocardiography
1
Carvedilol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiomyopathies
×
Echocardiography
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled